Meet PJP at World ADC San Diego 2026
- 12–15 October 2026
- San Diego, CA
- Booth 33
- Poster 9, Tuesday 13 October (Day 1)
Ask us during World ADC...
Early ADC programmes rarely have the drug substance they need, but they still need formulation and lyophilisation data they can file on. Richard Park and Fabian Meier will be at booth 33 throughout the conference to talk through how to get there with milligrams, not grams.
See our poster
Getting to your MVP: preclinical strategies for ADC formulation and lyophilization using minimal sample quantities
- Presented by Richard Park
- Poster 9
- Tuesday 13 October (Day 1)
- How to select buffers and excipients at milligram scale, with real-time and accelerated stability data
- How to run liquid and lyophilised candidates side by side, including cake quality and reconstitution
- How that data sets out a minimum viable formulation path into the clinic
Can’t make the session?
Bring us your problem
We love to talk about problems in-person whenever possible. If you have an opportunity to share your current situation during World ADC, we’d love to hear about it!
- Too little material to screen properly. We can start preformulation screening with 35 mg.
- A lyophilisation cycle that’s too long or won’t transfer to your manufacturer’s freeze-dryer.
- High concentration or subcutaneous. Whether your ADC can get there, and what it will take.
- In-use stability. Proof that your ADC survives the IV bag, line and filter, not just the vial.
- Tech transfer. Handing over to your CDMO without surprises.
- Modality and DAR
- Development stage and next milestone
- How much material you have
- Target presentation: liquid or lyophilised, vial, IV or SC
ADC programmes completed
advanced to GMP manufacturing
to project start
Who you’ll meet
Every meeting is with both of us, so you get a scientific answer and clear next steps in the same conversation.
